Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant HIPEC with Raltitrexed or Oxaliplatin in Locally Advanced Colorectal Cancer
NCT02965248Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Nov 2016
- Primary completion
- Nov 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of raltitrexed, oxaliplatin in colorectal cancer (CRC), sponsored by Fudan University. Status: unknown.
02
Drugs
raltitrexedoxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02965248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02965248.